21 – ACQUIRED RESISTANCE OF TUMOR CELLS TO L-PHENYLALANINE MUSTARD: IMPLICATIONS FOR THE DESIGN OF A CLINICAL TRIAL INVOLVING GLUTATHIONE DEPLETION